Pfizer (PFE) EBITDA Margin Growth (5y) (2014 - 2026)
Pfizer (PFE) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.51 Bn | 632.75 Bn | 17.26 Bn |
| 2 | AbbVie | 470.18 Bn | 463.61 Bn | 12.70 Bn |
| 3 | Merck | 376.85 Bn | 369.71 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.27 Bn | 295.58 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.42 Bn | 252.52 Bn | 12.86 Bn |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.16 Bn | 178.98 Bn | 6.22 Bn |
| 8 | Pfizer | 159.30 Bn | 147.60 Bn | 10.94 Bn |
| 9 | Gsk | 106.12 Bn | 101.95 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -733.00 |
| Mar 29, 2026 | -96.00 |
| Sep 28, 2025 | 546.00 |
| Jun 29, 2025 | -35,490.00 |
| Mar 30, 2025 | -188.00 |
| Sep 29, 2024 | -234.00 |
| Jun 30, 2024 | -4,301.00 |
| Mar 31, 2024 | -658.00 |
| Dec 31, 2023 | 3,347.00 |
| Jul 2, 2023 | -21,115.00 |
| Apr 2, 2023 | -23,707.00 |
| Jul 3, 2022 | -3,329.00 |
| Apr 3, 2022 | -4,018.00 |
| Oct 3, 2021 | -4,145.00 |
| Jul 4, 2021 | -3,993.00 |
| Apr 4, 2021 | -3,915.00 |
| Jun 28, 2020 | -5,100.00 |
| Mar 29, 2020 | -4,403.00 |
| Sep 29, 2019 | -476.00 |
| Jun 30, 2019 | 243.00 |